- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2016-002733-30.
Displaying page 1 of 1.
EudraCT Number: 2016-002733-30 | Sponsor Protocol Number: 204810 | Start Date*: 2017-03-08 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A Phase I/II, randomised, observer-blind, controlled multi-country study to assess the safety, reactogenicity and immunogenicity of a single intramuscular dose of GSK Biologicals’ investigational R... | |||||||||||||
Medical condition: Healthy pregnant women (Respiratory Syncytial Virus) | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended) FI (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
